0001209191-21-071172.txt : 20211223 0001209191-21-071172.hdr.sgml : 20211223 20211223185853 ACCESSION NUMBER: 0001209191-21-071172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211221 FILED AS OF DATE: 20211223 DATE AS OF CHANGE: 20211223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christian Waage CENTRAL INDEX KEY: 0001553179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 211518535 MAIL ADDRESS: STREET 1: RECEPTOS, INC. STREET 2: 10835 ROAD TO THE CURE, SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582514400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-21 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001553179 Christian Waage 4242 CAMPUS POINT COURT SUITE 200 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2021-12-21 4 S 0 300 9.7345 D 3200 D Common Stock 2021-12-22 4 A 0 10452 0.00 A 13652 D Stock Option (Right to Buy) 9.81 2021-12-22 4 A 0 20903 0.00 A 2031-12-22 Common Stock 20903 20903 D The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021. The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. The shares were granted as restricted stock units which vest in full on December 22, 2022. The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. /s/ Lisa Peraza Attorney-in-fact for Christian Waage 2021-12-23